TY  - JOUR
AU  - Turzanski-Fortner, Renée
AU  - Trewin-Nybråten, Cassia B
AU  - Paulsen, Torbjørn
AU  - Langseth, Hilde
TI  - Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway.
JO  - International journal of cancer
VL  - 153
IS  - 5
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2023-01037
SP  - 969-978
PY  - 2023
N1  - #EA:C020# / 2023 Sep 1;153(5):969-978
AB  - Contemporary population-based data on ovarian cancer survival using current subtype classifications and by surgical status are sparse. We evaluated 1-, 3-, 5- and 7-year relative (and overall) survival, and excess hazards in patients with borderline tumors or invasive epithelial ovarian cancer diagnosed 2012 to 2021 in a nationwide registry-based cohort in Norway. Outcomes were evaluated by histotype, FIGO stage, cytoreduction surgery and residual disease. Overall survival was evaluated for non-epithelial ovarian cancer. Survival of women with borderline ovarian tumors was excellent (≥98.0
KW  - cytoreduction surgery (Other)
KW  - histotype (Other)
KW  - ovarian cancer (Other)
KW  - stage (Other)
KW  - survival (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37226635
DO  - DOI:10.1002/ijc.34576
UR  - https://inrepo02.dkfz.de/record/276228
ER  -